EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects

Maria Carolina Yi Lin Lee, Juliana Alves Camargo, Giovana Caetano Vilas Boas, Karina Serafim Silva, Luana Pereira Silva, Carolina Mie Mioshi, Ruan Pimenta, Iran Amorim Silva, Katia Ramos Moreira Leite, William Carlos Nahas, Sabrina T Dos Reis

Molecular Biology Reports · 2026-12 · 53 (1)

DOI: 10.1007/s11033-026-12129-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 19.06.2026. Verfasst von Maria Carolina Yi Lin Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Investigation (LIM55), Urology Department, University of São Paulo Medical School, Av. Dr. Arnaldo 455, 2° floor, room 2145 - C…. Hauptthemen laut MEDLINE: MicroRNAs, CRISPR-Cas Systems, Urinary Bladder Neoplasms, Gene Editing. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade De São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urothelial carcinoma, the predominant form of bladder cancer, represents a global public health challenge due to its high rates of recurrence and progression. At the molecular level, microRNA-21 (miR-21) has been characterized as an “oncomir” because of its ability to negatively regulate tumor suppressor genes, thereby promoting tumor survival and progression. In this context, the CRISPR/Cas9 system has emerged as a precise genome-editing tool.

Objective

To investigate the biological effects of miR-21 modulation using CRISPR/Cas9-mediated genome editing in the T24 high-grade invasive urothelial carcinoma cell line.

Methods

The CRISPR/Cas9 system was delivered as a ribonucleoprotein (RNP) complex. Editing efficiency was assessed using quantitative reverse transcription PCR (RT-qPCR). Functional effects were evaluated through gene expression assays, cell migration assays, as well as Matrigel invasion assays. The presence of the Cas9 protein was confirmed by immunofluorescence.

Results

CRISPR/Cas9 treatment targeting miR-21 showed a trend toward reduced miR-21 expression (p = 0.0563), although this did not reach statistical significance. A statistically significant increase in MASPIN (p < 0.0001) and PDCD4 (p = 0.0239), as well as a trend toward increased PTEN expression (p = 0.055), was observed following treatment. Functionally, a significant reduction in the migratory capacity of edited cells was observed after 48 h (p = 0.0334). The presence of Cas9 was successfully confirmed in transfected cells.

Conclusion

These findings suggest that CRISPR/Cas9-mediated modulation of miR-21 may influence tumor suppressor pathways and reduce the migratory potential of urothelial carcinoma cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsCRISPR-Cas SystemsUrinary Bladder NeoplasmsGene EditingHumansCell Line, TumorCell MovementGene Expression Regulation, NeoplasticPTEN PhosphohydrolaseCell ProliferationRNA-Binding ProteinsApoptosis Regulatory Proteins

Stichwörter der Autor:innen

Bladder cancerCRISPR/Cas9miR-21

Substanzen

MicroRNAsMIRN21 microRNA, humanPTEN PhosphohydrolaseRNA-Binding ProteinsPDCD4 protein, humanApoptosis Regulatory ProteinsPTEN protein, human

Autor:innen und Institutionen

  • Laboratory of Medical Investigation (LIM55), Urology Department, University of São Paulo Medical School, Av. Dr. Arnaldo 455, 2° floor, room 2145 - Cerqueira Cesar, São Paulo, Brazil.
  • Precision Immunology Institute, Department of Immunology and Immunotherapy, and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, United States.
  • Uro-Oncology Group, Urology Department, Institute of Cancer State of São Paulo (ICESP), São Paulo, Brazil.
  • Laboratory of Medical Investigation (LIM55), Urology Department, University of São Paulo Medical School, Av. Dr. Arnaldo 455, 2° floor, room 2145 - Cerqueira Cesar, São Paulo, Brazil. sabrinareis@usp.br.
  • Moriah Institute of Science and Education (MISE), Hospital Moriah, São Paulo, Brazil. sabrinareis@usp.br.

Förderung

  • Universidade De São Paulo

Zitieren

APA

Yi Lin Lee, M. C., Camargo, J. A., Caetano Vilas Boas, G., Silva, K. S., Silva, L. P., Mioshi, C. M., Pimenta, R., Silva, I. A., Ramos Moreira Leite, K., Nahas, W. C., & Dos Reis, S. T. (2026). CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. Molecular Biology Reports, 53(1). https://doi.org/10.1007/s11033-026-12129-7

Vancouver

Yi Lin Lee MC, Camargo JA, Caetano Vilas Boas G, Silva KS, Silva LP, Mioshi CM, et al. CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. Molecular Biology Reports. 2026;53(1). doi:10.1007/s11033-026-12129-7

BibTeX
@article{YiLinLee2026,
  author = {Yi Lin Lee, Maria Carolina and Camargo, Juliana Alves and Caetano Vilas Boas, Giovana and Silva, Karina Serafim and Silva, Luana Pereira and Mioshi, Carolina Mie and Pimenta, Ruan and Silva, Iran Amorim and Ramos Moreira Leite, Katia and Nahas, William Carlos and Dos Reis, Sabrina T},
  title = {CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects},
  journal = {Molecular Biology Reports},
  year = {2026},
  volume = {53},
  number = {1},
  doi = {10.1007/s11033-026-12129-7}
}
Kostenlos starten →